Accepted answer
Content assay requires a reference standard of known purity and traceability, which is why it costs more than purity testing does.
The single most common reason for disagreement between a supplier content figure and an independent assay is using different standards.
Reconciling gross mass to label claim
| Component | Typical share | Counted in purity? | Counted in content? |
|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
Concretely, if a sample shows high purity but low content, the explanation is usually that the standard used for quantitation had a different purity than claimed.
The relative standard deviation on replicate quantitations of a homogeneous sample should be below two per cent when the method is under control.
One qualification: a single result from a single vial is a point estimate, and repeating the assay on a second aliquot is worth doing if the first result is surprising.
If a supplier gives you content without the standard's purity, ask them to provide it.